If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
115.20    -2.00 (-1.71%)
Bid:
115.20
Ask:
116.60
Spread: 1.40 (1.215%)
Market Cap: £288.38m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Director/PDMR Shareholding

20 Mar 2025 10:18

RNS Number : 5024B
Vanquis Banking Group PLC
20 March 2025
Β 

Vanquis Banking Group plc ("the Company")

Director/PDMR Transaction - Initial Notification

Β 

The Company announces the following transactions in the Company's Ordinary Shares of 20 8/11p ("Ordinary Shares") undertaken by directors / persons discharging managerial responsibility ('PDMRs') and their persons closely associated ('PCAs').

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Dave Watts

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Vanquis Banking Group plc

b)

Β 

LEI

Β 

213800U93SZC44VXN635

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares of 20 8/11p

Β 

GB00B1Z4ST84

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Market purchase of 40,000 Ordinary Shares.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.57062

40,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

N/A (Single transaction)

e)

Β 

Date of the transaction

19 March 2025

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Name of authorised official of issuer responsible for making notification:

Elizabeth McClure, Deputy Company Secretary

Date of Notification:

20 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBBLFLEXLFBBV
Date   Source Headline
19th Mar 20249:00 amRNSHolding(s) in Company
18th Mar 20244:57 pmRNSHolding(s) in Company
13th Mar 20244:15 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSUpdate ahead of strategy seminar
29th Feb 20244:30 pmRNSTotal Voting Rights
1st Feb 20247:05 amRNSDirectorate Change
1st Feb 20247:00 amRNSFull year trading update
31st Jan 20244:30 pmRNSTotal Voting Rights
23rd Jan 20245:11 pmRNSHolding(s) in Company
15th Jan 20243:00 pmRNSBlock listing Interim Review
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20233:01 pmRNSHolding(s) in Company
30th Nov 20234:30 pmRNSTotal Voting Rights
9th Nov 20234:00 pmRNSPublication of Offering Circular
6th Nov 202311:48 amRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSDirectorate Change
31st Oct 20234:30 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSBlock Listing Application
17th Oct 20237:00 amRNSThird quarter trading statement
27th Sep 20237:00 amRNSChief Financial Officer Appointment
18th Sep 20235:52 pmRNSDirectorate Change
15th Sep 202310:53 amRNSHolding(s) in Company
13th Sep 20234:02 pmRNSHolding(s) in Company
11th Sep 20231:06 pmRNSHolding(s) in Company
11th Sep 202311:30 amRNSDirector/PDMR Shareholding
11th Sep 202310:11 amRNSHolding(s) in Company
31st Aug 20234:30 pmRNSTotal Voting Rights
25th Aug 202312:35 pmRNSHolding(s) in Company
15th Aug 20231:04 pmRNSHolding(s) in Company
14th Aug 20233:44 pmRNSHolding(s) in Company
9th Aug 20234:10 pmRNSHolding(s) in Company
9th Aug 20233:00 pmRNSDirector/PDMR Shareholding
7th Aug 20233:12 pmRNSIssue of Equity
7th Aug 20238:59 amRNSCFO Succession
1st Aug 20232:15 pmRNSDirector/PDMR Shareholding
31st Jul 20234:41 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSSnoop Acquisition
28th Jul 20237:00 amRNSInterim Results for six months ended 30 June 2023
26th Jul 20231:00 pmRNSHolding(s) in Company
14th Jul 20233:11 pmRNSBlock listing Interim Review
3rd Jul 20231:13 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSChair Appointment
27th Jun 20232:37 pmRNSHolding(s) in Company
27th Jun 20231:51 pmRNSHolding(s) in Company
1st Jun 20233:52 pmRNSHolding(s) in Company
31st May 20234:30 pmRNSTotal Voting Rights and Capital
25th May 20231:30 pmRNSResult of Annual General Meeting
25th May 20237:00 amRNSFirst quarter trading statement
19th May 20237:00 amRNSChairman succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.